Mrv1909 03022020412D 17 12 0 0 0 0 999 V2000 -3.6808 -0.2129 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 -2.9668 0.2004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2527 -0.2088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5387 0.2045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8246 -0.2045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1106 0.2088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6034 -0.2003 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 -2.9710 1.0273 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.5429 1.0313 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.5429 -0.6221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2611 -1.0313 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.8288 -1.0355 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 -0.1148 1.0355 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.7032 -0.1961 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.0983 -1.2427 0.0000 K 0 3 0 0 0 0 0 0 0 0 0 0 2.0983 0.7613 0.0000 K 0 3 0 0 0 0 0 0 0 0 0 0 2.0983 -0.1961 0.0000 K 0 3 0 0 0 0 0 0 0 0 0 0 2 3 1 0 0 0 0 2 8 2 0 0 0 0 4 9 1 0 0 0 0 3 4 1 0 0 0 0 4 10 1 0 0 0 0 10 11 2 0 0 0 0 4 5 1 0 0 0 0 10 12 1 0 0 0 0 1 2 1 0 0 0 0 6 13 2 0 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 M CHG 6 1 -1 7 -1 12 -1 15 1 16 1 17 1 M END > DBSALT002942 > drugbank > O.[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O > InChI=1S/C6H8O7.3K.H2O/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;1H2/q;3*+1;/p-3 > PJAHUDTUZRZBKM-UHFFFAOYSA-K > C6H7K3O8 > 324.409 > 323.90521166 > 7 > 24 > -2.983173693927355 > 14.234797247864794 > 1 > 1 > 0 > 0 > tripotassium 2-hydroxypropane-1,2,3-tricarboxylate hydrate > -0.70 > -1.3226874519999998 > -0.89 > 0 > -3 > 0 > -3 > 4.674836176324 > 3.0479515131680732 > -4.1856934502319305 > 140.62 > 68.1352 > 5 > 1 > 3.94e+01 g/l > rabeximod > 0 > DBSALT002942 > Potassium citrate monohydrate > DB09125 > Potassium citrate > 6100-05-6 > EE90ONI6FF $$$$